english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Erenumab (Aimovig°) for the prevention of migraine attacks: decrease in the frequency of attacks in some patients, but uncertainty over cardiovascular effects

In the September edition of Prescrire International: sartan medicines contaminated by impurities which are probable carcinogens

Carpal tunnel syndrome: sometimes drug-related

New drugs: investing in more informative clinical trials

Fluoroquinolones: use should be restricted due to severe adverse effects

"Top Texts of 2019", new from the editors of Prescrire International

Psychotic episode: which oral neuroleptic to choose? A choice tailored to each patient, based on the adverse effect profiles of the options

In the July-August issue of Prescrire International: emtricitabine + tenofovir disoproxil (Truvada° and other brands) for prevention of HIV infection in adolescents

Fentanyl (Actiq° and other brands) and other opioids: risk of increased pain

Prescrire's packaging review for 2018: ways to reduce dangers

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90